fludarabine phosphate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Fludarabine Phosphate.
Product ID | 25021-237_18f5feab-3c38-40f5-a595-6a6c66762af2 |
NDC | 25021-237 |
Product Type | Human Prescription Drug |
Proprietary Name | fludarabine phosphate |
Generic Name | Fludarabine Phosphate |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-12-15 |
Marketing End Date | 2020-06-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076349 |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | FLUDARABINE PHOSPHATE |
Active Ingredient Strength | 25 mg/mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2014-12-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076349 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-12-15 |
Marketing End Date | 2019-06-30 |
Ingredient | Strength |
---|---|
FLUDARABINE PHOSPHATE | 25 mg/mL |
SPL SET ID: | 763d6c6d-cfed-4813-8cc5-41e78d357845 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
16729-131 | FLUDARABINE PHOSPHATE | FLUDARABINE |
24201-237 | fludarabine phosphate | fludarabine phosphate |
25021-237 | fludarabine phosphate | fludarabine phosphate |
25021-242 | Fludarabine Phosphate | Fludarabine Phosphate |
45963-609 | Fludarabine phosphate | Fludarabine phosphate |
45963-621 | Fludarabine phosphate | Fludarabine phosphate |
59923-604 | Fludarabine Phosphate | Fludarabine Phosphate |
61703-344 | Fludarabine Phosphate | FLUDARABINE PHOSPHATE |
66758-046 | Fludarabine Phosphate | Fludarabine Phosphate |
63323-192 | Fludarabine | FLUDARABINE PHOSPHATE |